These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy? Saniabadi AR; Hanai H; Suzuki Y; Ohmori T; Sawada K; Yoshimura N; Saito Y; Takeda Y; Umemura K; Kondo K; Ikeda Y; Fukunaga K; Nakashima M; Beretta A; Bjarnason I; Lofberg R J Clin Apher; 2005 Oct; 20(3):171-84. PubMed ID: 15892107 [TBL] [Abstract][Full Text] [Related]
3. [Ulcerative colitis and intestinal bleeding]. Asakura H Nihon Rinsho; 1998 Sep; 56(9):2354-9. PubMed ID: 9780719 [TBL] [Abstract][Full Text] [Related]
4. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis. Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554 [TBL] [Abstract][Full Text] [Related]
5. Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis. Andoh A; Ogawa A; Kitamura K; Inatomi O; Fujino S; Tsujikawa T; Sasaki M; Mitsuyama K; Fujiyama Y J Gastroenterol; 2004 Dec; 39(12):1150-7. PubMed ID: 15622478 [TBL] [Abstract][Full Text] [Related]
7. Ulcerative colitis: pathogenesis, diagnosis, and current treatment. Griffel LH; Das KM J Assoc Acad Minor Phys; 1996; 7(3):63-9. PubMed ID: 8803417 [TBL] [Abstract][Full Text] [Related]
8. Acute severe ulcerative colitis: timing is everything. Gulliford SR; Limdi JK Postgrad Med J; 2011 Mar; 87(1025):215-22. PubMed ID: 21242575 [TBL] [Abstract][Full Text] [Related]
9. Flare up of ulcerative colitis during pregnancy treated by adsorptive granulocyte and monocyte apheresis: therapeutic outcomes in three pregnant patients. Takahashi H; Sugawara K; Sugimura M; Iwabuchi M; Mano Y; Ukai K; Tadokoro K Arch Gynecol Obstet; 2013 Aug; 288(2):341-7. PubMed ID: 23404436 [TBL] [Abstract][Full Text] [Related]
10. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. Hibi T; Inoue N; Ogata H; Naganuma M J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869 [TBL] [Abstract][Full Text] [Related]
11. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452 [TBL] [Abstract][Full Text] [Related]
12. Granulocytapheresis in the treatment of patients with active ulcerative colitis. Bresci G Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):639-43. PubMed ID: 19072341 [TBL] [Abstract][Full Text] [Related]
13. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. Murata Y; Ishiguro Y; Itoh J; Munakata A; Yoshida Y J Gastroenterol; 1995 Nov; 30 Suppl 8():56-60. PubMed ID: 8563892 [TBL] [Abstract][Full Text] [Related]
14. Microarray analysis of leukocytapheresis-induced changes in gene expression patterns of peripheral blood mononuclear cells in patients with ulcerative colitis. Yagi Y; Andoh A; Ogawa A; Bamba S; Tsujikawa T; Sasaki M; Mitsuyama K; Fujiyama Y Ther Apher Dial; 2007 Oct; 11(5):331-6. PubMed ID: 17845392 [TBL] [Abstract][Full Text] [Related]